The authors discuss the success of the Pioneer ACO model and the Comprehensive Primary Care Initiative, among others. They outline an agenda that includes engaging managed care stakeholders, so that both public and private payers are moving toward value-based payment.
ASCO says that it's Patient-Centered Oncology Payment model meets the criteria for an Alternative Payment Model as defined by Congress in the Medicare Access and CHIP Reauthorization Act of 2015, which replaced the Sustainable Growth Rate formula.
The article, published in the Journal of Hospital Medicine, found that large urban hospitals that serve as a safety net for patients with lower socioeconomic status, are at a disadvantage due to factors outside of their control.
Karen Davis, director of Roger C. Lipitz Center for Integrated Health Care at Johns Hopkins University, says increasing resources available for home treatments and services and support for family caregivers of the elderly and those with debilitating diseases might work to reduce reliance on costly nursing homes for those afflicted.
The use of an 80% threshold or other binary cut point may be insufficient for characterizing the relationship between medication adherence and Medicare spending.
If adopted, the active surveillance threshold would give physicians a tool in the management of men with localized prostate cancer and could spare many aggressive therapy or radiation and its side effects.
In 2014, Medicare telemedicine reimbursement totaled $13.9 million, a number that has steadily increased since 2008, according to the Robert J. Waters Center for Telehealth and eHealth Law.
This study examines factors impacting the receipt of an outpatient colonoscopy by VA or non-VA providers in older veterans dually eligible for VA/Medicare benefits.
Only 1.2% of community-dwelling Medicare beneficiaries who received hospital-based observation services in 2010 were discharged to an SNF not covered by Medicare.
The average per capita spending difference between people with and without diabetes was $10,310 from 2009 to 2013, according to a new report from the Health Care Cost Institute.
Designed to improve physician payment, the Medicare Access and CHIP Reauthorization Act of 2015 is a step in the right direction, and certainly better than the alternative, but it's not magic and it's not enough.
Since the introduction of the Oncology Care Model, oncologists have raised numerous questions as they weigh whether to apply for participation.
An independent review of Medicare payments reveals that 42% of the healthcare dollars Medicare paid to providers in its fee-for-service program in 2013 were designed to boost the value of care patients receive.
A study conducted at the University of Maryland School of Public Health, published in the journal Health Affairs, evaluated the results of an intervention to connect low-income uninsured and Medicaid patients to a reliable source of primary healthcare.
When 5% of Medicaid recipients account for 54% of spending, cost is just the beginning of the problem.
CMS' decision to pay primary care physicians to coordinate for seniors with multiple chronic conditions cannot soon enough, if a study in Clinical Diabetes is any sign.
The Pioneer ACO Model successfully reported smaller increases in total Medicare expenditures and reductions in health service utilization, for savings of approximately $385 million during the first 2 years compared with general Medicare fee-for-service.
As accountable care organizations work to deliver population health, patient satisfaction, and cost savings, the need to engage patients as partners in their own healthcare has never been more essential. The ACO and Emerging Healthcare Delivery Coalition, an initiative of The American Journal of Managed Care, gathered this week at the historic Hotel del Coronado in San Diego, California, to explore ways to make patients the starting points of healthcare, not just its recipients.
Patients at hospitals with high rates of skilled nursing facility discharge usually have poorer outcomes and higher downstream spending, according to researchers from Massachusetts Institute of Technology and Vanderbilt University.
The federal government popped the cap off drug spending on Thursday, detailing doctor-by-doctor and drug-by-drug how Medicare and its beneficiaries spent $103 billion on pharmaceuticals in 2013.
Today's call for Medicare to cover the Diabetes Prevention Program is part of a broader effort by advocacy groups and the AMA to identify those with prediabetes and intervene before people develop full-blown diabetes.